Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.
Frequently asked questions
What sector does Theraclion SA (TCLIF) operate in?
Theraclion SA belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Theraclion SA (TCLIF) current stock price?
As of the latest data, Theraclion SA stock price is $0.53, with a previous close of $0.53.
What is Theraclion SA (TCLIF) current market capitalization?
Theraclion SA market cap is approximately 39.25 million.
What is Theraclion SA (TCLIF) Earnings Per Share (EPS)?
The trailing EPS is -$0.11.
What is Theraclion SA (TCLIF) EBITDA?
Theraclion SA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.89 million.
Does Theraclion SA (TCLIF) pay dividends?
No. Theraclion SA does not pay a dividend.
When is Theraclion SA (TCLIF) next earnings report?
Theraclion SA is expected to release its next earnings report on September 30, 2026.
What is Theraclion SA (TCLIF) beta (volatility) score?
Theraclion SA has a beta of 0.450, indicating lower volatility than the overall market.
